Neurotrophic factors (NTFs) are a pleiotropic group of secreted growth factors that regulate multiple aspects of neuronal development, including the regressive event of cell death. Skeletal muscleinnervating lower motoneurons (MNs) of the brain stem and spinal cord comprise one population of central neurons in which programmed cell death (PCD) during embryogenesis has been actively investigated, as much for reasons of technical facility as clinical relevance. The precise identity of NTF-dependent MNs has remained unclear, with most studies simply reporting losses or gains across the entire spinal cord or individual brain-stem nuclei. However, MNs are grouped into highly heterogenous populations based on transcriptional identity, target innervation, and physiological function. Therefore, recent work has focused on the effects of NTF overexpression or deletion on the survival of these MN subpopulations. Together with the recent progress attained in the generation of conditional mutant mice, in which the function of an NTF or its receptor can be eliminated specifically in MNs, these recent studies have begun to define the differential trophic requirements for MN subpopulations during PCD. The intent of this review is to summarize these recent findings and to discuss their significance with respect to neurotrophic theory.
Airaksinen MS, Arumäe U., Rauvala H., Saarma M.1999. GDNF family neurotrophic factor signaling: four masters, one servant?Mol Cell Neurosci13(5):313-25.
2.
Alcántara S., Frisén J., del Río JA, Soriano E., Barbacid M., Silos-Santiago I.1997. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci17(10): 3623-33.
3.
Appel SH1981. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol10(6):499-505.
4.
Arce V., Pollock RA, Philippe JM, Pennica D., Henderson CE, deLapeyrière O.1998. Synergistic effects of schwann- and muscle-derived factors on motoneuron survival involve GDNF and cardiotrophin-1 (CT-1). J Neurosci18(4):1440-8.
5.
Arce V., Garces A., de Bovis B., Filippi P., Henderson CE, Pettmann B., deLapeyrière O.1999. Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J Neurosci Res55(1):119-26.
6.
Barbacid M.1995. Structural and functional properties of the TRK family of neurotrophin receptors. Ann N Y Acad Sci766:442-58.
7.
Barde Y.-A. 1989. Trophic factors and neuronal survival. Neuron2(6):1525-34.
8.
Birchmeier C., Gherardi E.1998. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol8(10):404-10.
9.
Buss RR, Sun W., Oppenheim RW2006. Adaptive roles of programmed cell death during nervous system development. Annu Rev Neurosci29:1-35.
10.
Caroni P.1993. Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system. Ann N Y Acad Sci692:209-22.
11.
Caroni P., Schneider C., Kiefer MC, Zapf J.1994. Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol125(4):893-902.
12.
Collin R.1906. Recherches cytologiques sur le developpement de la cellule nerveus. Nevraxe8:181-303.
13.
D'Costa AP, Prevette DM, Houenou LJ, Wang S., Zackenfels K., Rohrer H., and others. 1998. Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons. J Neurobiol36(3):379-94.
14.
Davies AM1996. The neurotrophic hypothesis: where does it stand ? Philos Trans R Soc Lond B Biol Sci351(1338): 389-94.
15.
Dolcet X., Soler RM, Gould TW, Egea J., Oppenheim RW, Comella JX2001. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway . Mol Cell Neurosci18(6):619-31.
16.
Ellis RE, Yuan JY, Horvitz HR1991. Mechanisms and functions of cell death. Annu Rev Cell Biol7:663-98.
17.
Ferrara N., Gerber HP, LeCouter J.2003. The biology of VEGF and its receptors. Nat Med9(6):669-76.
18.
Ferri CC, Moore FA, Bisby MA1998. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J Neurobiol34(1):1-9.
19.
Forger NG, Prevette D., deLapeyrière O., de Bovis B., Wang S., Bartlett P., Oppenheim RW2003. Cardiotrophin-like cytokine/cytokinelike factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo . J Neurosci23(26):8854-8.
20.
Funakoshi H., Ohya W., Kadoyama K., Nakamura T.2007. ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor. Brain Nerve59(10):1195-202.
21.
Gould TW2008. In: Encyclopedia of bioscience. In press.
22.
Gould TW2009. Motor neuron trophic factors: therapeutic use in ALS?Front Biosci. In press.
23.
Gould TW, Oppenheim RW2004. The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo. J Neurosci24(19):4668-82.
24.
Gould TW, Yonemura S., Oppenheim RW, Ohmori S., Enomoto H.2008. The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes . J Neurosci28(9):2131-46.
25.
Grieshammer U., Lewandoski M., Prevette D., Oppenheim RW, Martin GR1998. Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss. Dev Biol197(2):234-47.
26.
Haase G., Dessaud E., Garcès A., de Bovis B., Birling M., Filippi P., and others. 2002. GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools. Neuron35(5):893-905.
27.
Hamburger V.1958. Regression versus peripheral control of differentiation in motor hypoplasia. Am J Anat102(3):365-409.
28.
Hamburger V.1975. Cell death in the development of the lateral motor column of the chick embryo. J Comp Neurol160(4):535-46.
29.
Hamburger V., Levi-Montalcini R.1949. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions . J Exp Zool111(3): 457-501.
30.
Helmbacher F., Dessaud E., Arber S., deLapeyrière O., Henderson CE, Klein R., Maina F.2003. Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools. Neuron39(5):767-77.
31.
Henderson CE, Yamamoto Y., Livet J., Arce V., Garces A., deLapeyrière O.1998. Role of neurotrophic factors in motoneuron development . J Physiol Paris92(3-4):279-81.
32.
Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C., Armanini M., and others. 1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science266(5187):1062-4.
33.
Hibi M., Nakajima K., Hirano T.1996. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med74(1):1-12.
34.
Hobson MI, Green CJ, Terenghi G.2000. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat197(Pt 4):591-605.
35.
Holtmann B., Wiese S., Samsam M., Grohmann K., Pennica D., Martini R., Sendtner M.2005. Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. J Neurosci25(7):1778-87.
36.
Jones JI, Clemmons DR1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev16(1):3-34.
37.
Korsching S.1993. The neurotrophic factor concept: a re-examination . J Neurosci13(7):2739-48.
38.
Kramer ER, Knott L., Su F., Dessaud E., Krull CE, Helmbacher F., Klein R.2006. Cooperation between GDNF/Ret and ephrinA/ EphA4 signals for motor-axon pathway selection in the limb. Neuron50(1):35-47.
39.
Kucera J., Ernfors P., Walro J., Jaenisch R.1995. Reduction in the number of spinal motor neurons in neurotrophin-3-deficient mice. Neuroscience69(1):321-30.
40.
Lambrechts D., Carmeliet P.2006. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta1762(11-12):1109-21.
41.
Landmesser LT2001. The acquisition of motoneuron subtype identity and motor circuit formation. Int J Dev Neurosci19(2): 175-82.
42.
Levi-Montalcini, R., Cohen, S.1960. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Ann N Y Acad Sci85(1):324-41.
43.
Lewis ME, Neff NT, Contreras PC, Stong DB, Oppenheim RW, Grebow PE, Vaught JL1993. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Exp Neurol124(1):73-88.
44.
Liu X., Jaenisch R.2000. Severe peripheral sensory neuron loss and modest motor neuron reduction in mice with combined deficiency of brain-derived neurotrophic factor, neurotrophin 3 and neurotrophin 4/5. Dev Dyn218(1):94-101.
45.
Maina F., Klein R.1999. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci2(3):213-7.
46.
Maina F., Panté G., Helmbacher F., Andres R., Porthin A., Davies AM, and others. 2001. Coupling Met to specific pathways results in distinct developmental outcomes. Mol Cell7(6):1293-306.
47.
Mason JL, Xuan S., Dragatsis I., Efstratiadis A., Goldman JE2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci23(20):7710-8.
48.
McKay SE, Garner A., Caldero J., Tucker RP, Large T., Oppenheim RW1996. The expression of trkB and p75 and the role of BDNF in the developing neuromuscular system of the chick embryo. Development122(2):715-24.
49.
McLennan IS1982. Size of motoneuron pool may be related to number of myotubes in developing muscle. Dev Biol92(1):263-5.
50.
Minichiello L., Klein R.1996. TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev10(22):2849-58.
51.
Moore MW, Klein RD, Fariñas I., Sauer H., Armanini M., Phillips H., and others. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature382(6586):76-9.
52.
Near SL, Whalen LR, Miller JA, Ishii DN1992. Insulin-like growth factor II stimulates motor nerve regeneration . Proc Natl Acad Sci USA89(24):11716-20.
53.
Nguyen QT, Parsadanian AS, Snider WD, Lichtman JW1998. Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science279(5357): 1725-9.
54.
Oppenheim RW1981. Neuronal cell death and some related regressive phenomena during neurogenesis: a selective historical review and progress report. In: Cowan WM, editor. Studies in developmental neurobiology. Oxford: Oxford University Press. p 74-133.
55.
Oppenheim RW1996. Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron17(2):195-7.
56.
Oppenheim RW1991. Cell death during development of the nervous system . Annu Rev Neurosci14:453-501.
57.
Oppenheim RW, Prevette D., Haverkamp LJ, Houenou L., Yin QW, McManaman J.1993. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo. J Neurobiol24(8): 1065-79.
58.
Oppenheim RW, Houenou L., Parsadanian AS, Prevette D., Snider WD, Shen L.2000. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci20(13):5001-11.
59.
Oppenheim RW, Wiese S., Prevette D., Armanini M., Wang S., Houenou LJ, and others. 2001. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci21(4):1283-91.
60.
Pennica D., Arce V., Swanson TA, Vejsada R., Pollock RA, Armanini M., and others. 1996. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron17(1):63-74.
61.
Pu SF, Zhuang HX, Marsh DJ, Ishii DN1999. Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy . J Neurosci Res55(1):9-16.
62.
Purves D.1988. Body and brain: a trophic theory of neural connections . Cambridge (MA): Harvard University Press.
63.
Reddy LV, Koirala S., Sugiura Y., Herrera AA, Ko CP2003. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron40(3): 563-80.
64.
Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V., Yamaai T., Lewin GR, Birchmeier C.1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature389(6652): 725-30.
65.
Rind HB, Butowt R., von Bartheld CS2005. Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin. J Neurosci25(3):539-49.
66.
Roccisana J., Reddy V., Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A.2005. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes54(7):2090-102.
67.
Sánchez MP, Silos-Santiago I., Frisén J., He B., Lira SA, Barbacid M.1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature382(6586):70-3.
68.
Schwarz Q., Gu C., Fujisawa H., Sabelko K., Gertsenstein M., Nagy A., and others. 2004. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev18(22): 2822-34.
69.
Sendtner M., Holtmann B., Kolbeck R., Thoenen H., Barde Y.-A. 1992. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature360(6406): 757-9.
70.
Sendtner M., Pei G., Beck M., Schweizer U., Wiese S.2000. Developmental motoneuron cell death and neurotrophic factors . Cell Tissue Res301(1):71-84.
71.
Silos-Santiago I., Fagan AM, Garber M., Fritzsch B., Barbacid M.1997. Severe sensory deficits but normal CNS development in newborn mice lacking TrkB and TrkC tyrosine protein kinase receptors. Eur J Neurosci9(10):2045-56.
72.
Snider WD1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell77(5):627-38.
73.
Takahashi M.2001. The GDNF/RET signaling pathway and human diseases . Cytokine Growth Factor Rev12(4):361-73.
74.
Thoenen H.1991. The changing scene of neurotrophic factors. Trends Neurosci14(5):165-70.
75.
Tolosa L., Mir M., Asensio VJ, Olmos G., Lladó J.2008. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem105(4):1080-90.
76.
Vicario-Abejón C., Fernández-Moreno C., Pichel JG, de Pablo F.2004. Mice lacking IGF-I and LIF have motoneuron deficits in brain stem nuclei. Neuroreport15(18):2769-72.
Woolley A., Sheard P., Dodds K., Duxson M.1999. Alpha motoneurons are present in normal numbers but with reduced soma size in neurotrophin-3 knockout mice. Neurosci Lett272(2):107-10.
79.
Woolley AG, Sheard PW, Duxson MJ2005. Neurotrophin-3 null mutant mice display a postnatal motor neuropathy. Eur J Neurosci21(8):2100-10.
80.
Wright, DE, Zhou L., Kucera J., Snider WD1997. Introduction of a neurotrophin-3 transgene into muscle selectively rescues proprioceptive neurons in mice lacking endogenous neurtrophin-3 . Neuron19(3):503-17.
81.
Xu QG, Li XQ, Kotecha SA, Cheng C., Sun HS, Zochodne DW2004. Insulin as an in vivo growth factor. Exp Neurol188(1):43-51.
82.
Yamamoto Y., Livet J., Pollock RA, Garces A., Arce V., deLapeyrière O., Henderson CE1997. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a sub-population of embryonic motoneurons. Development124(15):2903-13.
83.
Yadav A., Kalita A., Dhillon S., Banerjee K.2005. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J Biol Chem280(36): 31830-40.
84.
Zhao Z., Alam S., Oppenheim RW, Prevette DM, Evenson A., Parsadanian A.2004. Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp Neurol190(2):356-72.
